Elzasonan hydrochloride
Alternative Names: CP 448187; CP 448187-01; ElzasonanLatest Information Update: 13 Aug 2013
At a glance
- Originator Pfizer
- Class Antidepressants; Small molecules
- Mechanism of Action Serotonin 1B receptor antagonists; Serotonin 1D receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder; Obsessive-compulsive disorders
Most Recent Events
- 13 Aug 2013 Discontinued - Phase-II for Obsessive-compulsive disorders in USA (unspecified route)
- 31 Dec 2005 No development reported - Phase-II for Obsessive-compulsive disorders in USA (unspecified route)
- 28 Nov 2002 Phase-II clinical trials in Obsessive-compulsive disorders in USA (unspecified route)